Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (346)

Clear all filters
Clear all filters

Defactinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

Focal Adhesion Kinase (FAK) Inhibitor

Depatuxizumab Mafodotin

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Solid Tumour

Drug Class / Mechanism

ADC

Derazantinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

FGFR Inhibitor

Dinaciclib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

CDK Inhibitor

Dinutuximab

Targeted Therapy (Antibody)

Therapeutic Category

Targeted Therapy (Antibody)

Oncology Type

Solid Tumour (Sarcoma/Neuroblastoma)

Drug Class / Mechanism

PDGFR / GD2 Targeting Agent

Disitamab Vedotin

Targeted Therapy (Antibody / ADC)

Therapeutic Category

Targeted Therapy (Antibody / ADC)

Oncology Type

Solid Tumour (Breast/Gastric)

Drug Class / Mechanism

Anti-HER2 Agent

Divarasib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

RET / MET / KRAS / IDH Inhibitor

Donafenib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

Multi-Kinase / Anti-Angiogenic Inhibitor

Dovitinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

Multi-Kinase / Anti-Angiogenic Inhibitor

Elzovantinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

MET Inhibitor

Enasidenib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

RET / MET / KRAS / IDH Inhibitor

Ensartinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

ALK / ROS1 / NTRK Inhibitor